A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer - Concepedia

Concepedia

Publication | Open Access

A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer

DOI Full Paper Access

15

Citations

31

References

2023

Year

Clinton Yam, Elizabeth A. Mittendorf, Haven R. Garber, Ryan Sun, Senthil Damodaran, Rashmi K. Murthy, David L. Ramírez, Meghan Karuturi, Rachel M. Layman, Nuhad K. Ibrahim,

Breast Cancer Research and Treatment

Breast OncologyMedicinePharmacologyPhase Ii StudyBreast CancerAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyMolecular OncologyNeoadjuvant Atezolizumab

References

	Year	Citations

Page 1

Page 1